Latest News & Features
Americas
Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation. 11 July 2024
Careers
Firm adds West Coast IP team with expertise across tech and life sciences | New hires include former nationwide IP chair of full-service law firm. 11 July 2024
Europe
New Secretary of State previously vowed Labour would harness AI and "put it to work for everyone from every background” | Starmer’s government expected to adopt a tougher position on AI regulation and laws | Proposed regulatory innovation office would expedite decisions for “fast, clear and consistent regulation”. 9 July 2024
Biotechnology
Minnesota-based biotech firm says Intellia used its patented gene editing innovations | Regeneron paid Intellia $100m for R&D that infringed three patents, alleges BlueAllele. 9 July 2024
Unified Patent Court
Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | DexCom and Abbott dispute over technology for remotely monitoring blood glucose levels in diabetes patients. 9 July 2024
Europe
UK leg of global litigation over mRNA tech sees patents ruled valid and invalid | Justice Meade follows EPO in decision on Moderna’s EP 565 patent | Pfizer and German partner BioNTech on the hook for EP 949 | Opinion on Moderna’s COVID pledge also handed down. 4 July 2024
Careers
New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens. 4 July 2024
Americas
Biomodal claims New England Biolabs infringed eight patents licensed by US non-profit | Cambridge-based firm produces ‘duet platform’ encompassing genetics and epigenetics. 4 July 2024
Americas
List compiled by sister title features peer-reviewed IP lawyers from across six continents | 2024 edition “most comprehensive and rigorous” to date, says rankings editor | Data reveals gender ratio and practice area concentration by continent. 2 July 2024
Americas
As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger. 2 July 2024